190 related articles for article (PubMed ID: 20442710)
21. Identification of FimH derivatives as adjuvant vaccinated with PAc that enhance protection against Streptcoccus mutans colonization.
Liu Z; Chen J; Li W; Bi Y; Li Y; Fan M
Mol Cell Probes; 2019 Jun; 45():19-25. PubMed ID: 30940544
[TBL] [Abstract][Full Text] [Related]
22. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
[TBL] [Abstract][Full Text] [Related]
23. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response.
Ross ME; Caligiuri MA
Blood; 1997 Feb; 89(3):910-8. PubMed ID: 9028322
[TBL] [Abstract][Full Text] [Related]
24. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
[TBL] [Abstract][Full Text] [Related]
25. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA.
Schmidt KN; Leung B; Kwong M; Zarember KA; Satyal S; Navas TA; Wang F; Godowski PJ
J Immunol; 2004 Jan; 172(1):138-43. PubMed ID: 14688319
[TBL] [Abstract][Full Text] [Related]
26. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
Schilling JD; Mulvey MA; Vincent CD; Lorenz RG; Hultgren SJ
J Immunol; 2001 Jan; 166(2):1148-55. PubMed ID: 11145696
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
[TBL] [Abstract][Full Text] [Related]
28. The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo.
Ke M; Wang H; Zhang M; Tian Y; Wang Y; Li B; Yu J; Dou J; Xi T; Zhou C
Biochem Pharmacol; 2014 May; 89(1):119-30. PubMed ID: 24630931
[TBL] [Abstract][Full Text] [Related]
29. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.
Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ
Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492
[TBL] [Abstract][Full Text] [Related]
30. Production of TNF-alpha by murine bone marrow derived mast cells activated by the bacterial fimbrial protein, FimH.
Dreskin SC; Abraham SN
Clin Immunol; 1999 Mar; 90(3):420-4. PubMed ID: 10075872
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury.
Cairns BA; Barnes CM; Mlot S; Meyer AA; Maile R
J Trauma; 2008 Apr; 64(4):1069-77; discussion 1077-8. PubMed ID: 18404077
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62.
Goodridge HS; Marshall FA; Else KJ; Houston KM; Egan C; Al-Riyami L; Liew FY; Harnett W; Harnett MM
J Immunol; 2005 Jan; 174(1):284-93. PubMed ID: 15611251
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor and cytokine expression patterns of CD56+ T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons.
Saikh KU; Lee JS; Kissner TL; Dyas B; Ulrich RG
J Infect Dis; 2003 Nov; 188(10):1562-70. PubMed ID: 14624383
[TBL] [Abstract][Full Text] [Related]
34. Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors.
Qiu F; Maniar A; Diaz MQ; Chapoval AI; Medvedev AE
Innate Immun; 2011 Aug; 17(4):375-87. PubMed ID: 20682587
[TBL] [Abstract][Full Text] [Related]
35. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma).
Sun R; Gao B
Gastroenterology; 2004 Nov; 127(5):1525-39. PubMed ID: 15521020
[TBL] [Abstract][Full Text] [Related]
36. Bacterial lipopolysaccharide activates CD57-negative human NK cells.
Kanevskiy LM; Erokhina SA; Streltsova MA; Telford WG; Sapozhnikov AM; Kovalenko EI
Biochemistry (Mosc); 2014 Dec; 79(12):1339-48. PubMed ID: 25716727
[TBL] [Abstract][Full Text] [Related]
37. Evaluating vaccinia virus cytokine co-expression in TLR GKO mice.
Sutherland DB; Ranasinghe C; Regner M; Phipps S; Matthaei KI; Day SL; Ramshaw IA
Immunol Cell Biol; 2011 Aug; 89(6):706-15. PubMed ID: 21173782
[TBL] [Abstract][Full Text] [Related]
38. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
[TBL] [Abstract][Full Text] [Related]
39. NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis.
Souza-Fonseca-Guimaraes F; Parlato M; Fitting C; Cavaillon JM; Adib-Conquy M
J Immunol; 2012 Jun; 188(12):5850-8. PubMed ID: 22566566
[TBL] [Abstract][Full Text] [Related]
40. Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells.
Vosskuhl K; Greten TF; Manns MP; Korangy F; Wedemeyer J
J Immunol; 2010 Jul; 185(1):119-25. PubMed ID: 20511546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
